A test to differentiate between dementia with Lewy Bodies and Alzheimer's disease

A Diagnostic Test for Dementia with Lewy Bodies

NIH-funded research Cnd Life Sciences, INC. · NIH-10589126

This study is testing a new diagnostic test to help doctors tell the difference between dementia with Lewy Bodies and Alzheimer's disease, so that people can get the right treatment and care they need.

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionCnd Life Sciences, INC. NIH-funded
Lab location1 site (Scottsdale, UNITED STATES)
Project IDNIH-10589126 on NIH RePORTER

What this research studies

This research aims to validate a diagnostic test that can accurately distinguish between dementia with Lewy Bodies (DLB) and Alzheimer's disease (AD). DLB is a severe neurodegenerative condition that affects millions and is often misdiagnosed, leading to inappropriate treatment and care. The study focuses on identifying the presence of a specific misfolded protein, α-synuclein, which is associated with DLB. By developing a reliable test, the research seeks to improve diagnostic accuracy and patient management.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals experiencing cognitive decline who may be diagnosed with either dementia with Lewy Bodies or Alzheimer's disease.

Not a fit: Patients with other forms of dementia or those who do not exhibit cognitive decline may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to more accurate diagnoses for patients with dementia, allowing for better-targeted treatments and care.

How similar studies have performed: Previous research has shown promise in developing diagnostic tests for neurodegenerative diseases, but this specific approach to differentiate DLB from AD is relatively novel.

Where this research is happening

Scottsdale, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.